| Discovery of novel azetidine amides as potent small-molecule STAT3 inhibitors C Brotherton-Pleiss, P Yue, Y Zhu, K Nakamura, W Chen, W Fu, C Kubota, ... Journal of Medicinal Chemistry 64 (1), 695-710, 2020 | 21 | 2020 |
| Targeting stearoyl-CoA desaturase in solid tumors CS Kubota, PJ Espenshade Cancer research 82 (9), 1682-1688, 2022 | 16 | 2022 |
| SREBP-dependent regulation of lipid homeostasis is required for progression and growth of pancreatic ductal adenocarcinoma CT Ishida, SL Myers, W Shao, MR McGuire, C Liu, CS Kubota, ... bioRxiv, 2024.02. 04.578802, 2024 | 1 | 2024 |
| In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency CS Kubota, SL Myers, TT Seppala, RA Burkhart, PS Espenshade bioRxiv, 2024.05. 03.592368, 2024 | | 2024 |
| Identifying druggable lipid synthesis targets as novel therapeutics for pancreatic cancer. CS Kubota, CT Ishida, S Myers, PJ Espenshade CANCER RESEARCH 82 (22), 63-64, 2022 | | 2022 |
| Abstract B011: Identifying druggable lipid synthesis targets as novel therapeutics for pancreatic cancer CS Kubota, CT Ishida, S Myers, PJ Espenshade Cancer Research 82 (22_Supplement), B011-B011, 2022 | | 2022 |
| Novel nano-molar small-molecule STAT3 inhibitor series with antitumor activities against human breast cancer P Yue, F Lopez-Tapia, C Brotherton-Pleiss, C Kubota, J Chen, M Tius, ... Cancer Research 78 (13_Supplement), 4880-4880, 2018 | | 2018 |
